These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 6610570)

  • 1. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO; Morgan EL; Goodman MG; Chenoweth DE; Hugli TE
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement inhibits immune responses: C3 preparations inhibit the generation of human cytotoxic T lymphocytes.
    Ballas ZK; Feldbush TL; Needleman BW; Weiler JM
    Eur J Immunol; 1983 Apr; 13(4):279-84. PubMed ID: 6189721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do complement components and fragments affect cellular immunological function?
    Gelfand JA
    J Trauma; 1984 Sep; 24(9 Suppl):S118-24. PubMed ID: 6332921
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses.
    Morgan EL; Thoman ML; Weigle WO; Hugli TE
    J Immunol; 1983 Mar; 130(3):1257-61. PubMed ID: 6600480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    Meuth JL; Morgan EL; DiSipio RG; Hugli TE
    J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of secondary in vitro antibody responses by the third component of complement.
    Hobbs MV; Feldbush TL; Needleman BW; Weiler JM
    J Immunol; 1982 Mar; 128(3):1470-5. PubMed ID: 6460062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cell.
    Morgan EL; Thoman ML; Weigle WO; Hugli TE
    J Immunol; 1985 Jan; 134(1):51-7. PubMed ID: 3155469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive complement fragments in immunoregulation.
    Morgan EL; Thoman ML; Hoeprich PD; Hugli TE
    Immunol Lett; 1985; 9(4):207-13. PubMed ID: 3873407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
    Sundsmo JS
    J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the immune response by anaphylatoxins.
    Morgan EL
    Complement; 1986; 3(3):128-36. PubMed ID: 3542364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen.
    Schuurman RK; Gelfand EW; Dosch HM
    J Immunol; 1980 Aug; 125(2):820-6. PubMed ID: 6967091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of C3 in the immune response.
    Erdei A; Füst G; Gergely J
    Immunol Today; 1991 Sep; 12(9):332-7. PubMed ID: 1755944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
    Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
    J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune response by components of the complement cascade and their activated fragments.
    Weigle WO; Goodman MG; Morgan EL; Hugli TE
    Springer Semin Immunopathol; 1983; 6(2-3):173-94. PubMed ID: 6356429
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.
    Spry CJ; Lane JT; Vyakarnam A
    Immunology; 1977 Jun; 32(6):947-54. PubMed ID: 301855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.